Activation of glycogen phosphorylase with 5-aminoimidazole-4-carboxamide riboside (AICAR): Assessment of glycogen as a precursor of mannosyl residues in glycoconjugates

Jie Shang, Mark A. Lehrman

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

The experimental evaluation of the contribution of glycogen phosphorylase (GP) to biochemical pathways is limited to methods that raise cAMP, activating the cAMP-dependent protein kinase/phosphorylase kinase/GP cascade. Such methods convert the unphosphorylated form, "GPb," which catalyzes glycogenolysis only in the presence of appropriate allosteric activators such as AMP, to the phosphorylated, constitutively activated form, "GPa." However, activation of GP in this way is indirect, requires a functional cAMP kinase cascade, and is complicated by other actions of cAMP. Here, we demonstrate a strategy for the experimental manipulation of GP in intact dermal fibroblasts, involving activation by the membrane-permeable adenosine analog 5-aminoimidazole-4-carboxamide riboside (AICAR) and inhibition by caffeine and Pfizer compound CP-91149, which bind to GP at distinct sites. Potential complications because of activation of AMP-activated protein kinase by AICAR were assessed with metformin, which activates this kinase but does not activate GP. Using this strategy, we show that glycogen can be a significant and regulatable precursor of mannosyl units in lipid-linked oligosaccharides and glycoproteins.

Original languageEnglish (US)
Pages (from-to)12076-12080
Number of pages5
JournalJournal of Biological Chemistry
Volume279
Issue number13
DOIs
StatePublished - Mar 26 2004

Fingerprint

Glycogen Phosphorylase
Glycoconjugates
Glycogen
Chemical activation
Phosphorylase Kinase
Phosphotransferases
Glycogenolysis
AMP-Activated Protein Kinases
Metformin
Adenosine Monophosphate
Fibroblasts
Cyclic AMP-Dependent Protein Kinases
Caffeine
Adenosine
Glycoproteins
acadesine
Proteins
Membranes
Skin

ASJC Scopus subject areas

  • Biochemistry

Cite this

@article{4e704ba53cee4ff28782d86048d5870f,
title = "Activation of glycogen phosphorylase with 5-aminoimidazole-4-carboxamide riboside (AICAR): Assessment of glycogen as a precursor of mannosyl residues in glycoconjugates",
abstract = "The experimental evaluation of the contribution of glycogen phosphorylase (GP) to biochemical pathways is limited to methods that raise cAMP, activating the cAMP-dependent protein kinase/phosphorylase kinase/GP cascade. Such methods convert the unphosphorylated form, {"}GPb,{"} which catalyzes glycogenolysis only in the presence of appropriate allosteric activators such as AMP, to the phosphorylated, constitutively activated form, {"}GPa.{"} However, activation of GP in this way is indirect, requires a functional cAMP kinase cascade, and is complicated by other actions of cAMP. Here, we demonstrate a strategy for the experimental manipulation of GP in intact dermal fibroblasts, involving activation by the membrane-permeable adenosine analog 5-aminoimidazole-4-carboxamide riboside (AICAR) and inhibition by caffeine and Pfizer compound CP-91149, which bind to GP at distinct sites. Potential complications because of activation of AMP-activated protein kinase by AICAR were assessed with metformin, which activates this kinase but does not activate GP. Using this strategy, we show that glycogen can be a significant and regulatable precursor of mannosyl units in lipid-linked oligosaccharides and glycoproteins.",
author = "Jie Shang and Lehrman, {Mark A.}",
year = "2004",
month = "3",
day = "26",
doi = "10.1074/jbc.M400431200",
language = "English (US)",
volume = "279",
pages = "12076--12080",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "13",

}

TY - JOUR

T1 - Activation of glycogen phosphorylase with 5-aminoimidazole-4-carboxamide riboside (AICAR)

T2 - Assessment of glycogen as a precursor of mannosyl residues in glycoconjugates

AU - Shang, Jie

AU - Lehrman, Mark A.

PY - 2004/3/26

Y1 - 2004/3/26

N2 - The experimental evaluation of the contribution of glycogen phosphorylase (GP) to biochemical pathways is limited to methods that raise cAMP, activating the cAMP-dependent protein kinase/phosphorylase kinase/GP cascade. Such methods convert the unphosphorylated form, "GPb," which catalyzes glycogenolysis only in the presence of appropriate allosteric activators such as AMP, to the phosphorylated, constitutively activated form, "GPa." However, activation of GP in this way is indirect, requires a functional cAMP kinase cascade, and is complicated by other actions of cAMP. Here, we demonstrate a strategy for the experimental manipulation of GP in intact dermal fibroblasts, involving activation by the membrane-permeable adenosine analog 5-aminoimidazole-4-carboxamide riboside (AICAR) and inhibition by caffeine and Pfizer compound CP-91149, which bind to GP at distinct sites. Potential complications because of activation of AMP-activated protein kinase by AICAR were assessed with metformin, which activates this kinase but does not activate GP. Using this strategy, we show that glycogen can be a significant and regulatable precursor of mannosyl units in lipid-linked oligosaccharides and glycoproteins.

AB - The experimental evaluation of the contribution of glycogen phosphorylase (GP) to biochemical pathways is limited to methods that raise cAMP, activating the cAMP-dependent protein kinase/phosphorylase kinase/GP cascade. Such methods convert the unphosphorylated form, "GPb," which catalyzes glycogenolysis only in the presence of appropriate allosteric activators such as AMP, to the phosphorylated, constitutively activated form, "GPa." However, activation of GP in this way is indirect, requires a functional cAMP kinase cascade, and is complicated by other actions of cAMP. Here, we demonstrate a strategy for the experimental manipulation of GP in intact dermal fibroblasts, involving activation by the membrane-permeable adenosine analog 5-aminoimidazole-4-carboxamide riboside (AICAR) and inhibition by caffeine and Pfizer compound CP-91149, which bind to GP at distinct sites. Potential complications because of activation of AMP-activated protein kinase by AICAR were assessed with metformin, which activates this kinase but does not activate GP. Using this strategy, we show that glycogen can be a significant and regulatable precursor of mannosyl units in lipid-linked oligosaccharides and glycoproteins.

UR - http://www.scopus.com/inward/record.url?scp=1842478238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842478238&partnerID=8YFLogxK

U2 - 10.1074/jbc.M400431200

DO - 10.1074/jbc.M400431200

M3 - Article

C2 - 14729664

AN - SCOPUS:1842478238

VL - 279

SP - 12076

EP - 12080

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 13

ER -